Filter Results
:
(1,221)
Show Results For
-
All HBS Web
(1,221)
- People (1)
- News (178)
- Research (862)
- Events (4)
- Multimedia (5)
- Faculty Publications (372)
Show Results For
-
All HBS Web
(1,221)
- People (1)
- News (178)
- Research (862)
- Events (4)
- Multimedia (5)
- Faculty Publications (372)
- July 2021
- Supplement
CIAM: Home-Grown Shareholder Activism in France (B)
By: Charles C.Y. Wang, Tonia Labruyere and Vincent Dessain
This case is a complement to CIAM: Home-Grown Shareholder Activism in France (A) and describes the events after CIAM learned about a potential misuse of corporate assets at Altice/SFR.
View Details
Keywords:
Corporate Governance;
Valuation;
Investment Activism;
Accounting;
Strategy;
Financial Services Industry;
France
Wang, Charles C.Y., Tonia Labruyere, and Vincent Dessain. "CIAM: Home-Grown Shareholder Activism in France (B)." Harvard Business School Supplement 121-078, July 2021.
- 2002
- Chapter
Bridging the Gap: How Improved Information Can Help Companies Integrate Shareholder Value and Environmental Quality
By: Forest Reinhardt
Keywords:
Corporate Social Responsibility and Impact;
Business and Shareholder Relations;
Information;
Environmental Sustainability
Reinhardt, Forest. "Bridging the Gap: How Improved Information Can Help Companies Integrate Shareholder Value and Environmental Quality." In Environmental Performance Measurement: The Global Report 2001-2002, edited by Daniel Esty and Peter K. Cornelius. Oxford: Oxford University Press, 2002.
- January 2018
- Background Note
Shareholder Value Maximization, Fiduciary Duties, and the Business Judgement Rule: What Does the Law Say?
By: Rebecca Henderson and Tony L He
Henderson, Rebecca, and Tony L He. "Shareholder Value Maximization, Fiduciary Duties, and the Business Judgement Rule: What Does the Law Say?" Harvard Business School Background Note 318-097, January 2018.
- October 2000
- Case
Tree Values
By: Richard S. Ruback and Kathleen Luchs
Describes two alternative tree cutting strategies. The first is to cut all trees that are at least 12 inches in diameter at breast height. The second is to thin the forest by cutting less desirable trees immediately and harvesting the crop trees later. The case...
View Details
Keywords:
Strategy;
Decision Making;
Cash Flow;
Decision Choices and Conditions;
Management Practices and Processes;
Value Creation;
Forestry Industry
Ruback, Richard S., and Kathleen Luchs. "Tree Values." Harvard Business School Case 201-031, October 2000.
Value Shift
Today, corporate accountability is as vital to the bottom line as an effective business model. Value Shift makes a strong case for the merits of corporate responsibility and shows how a value-positive orientation contributes to superior performance through... View Details
- December 2013
- Article
How Do Staggered Boards Affect Shareholder Value? Evidence from a Natural Experiment
By: Alma Cohen and Charles C.Y. Wang
The well-established negative correlation between staggered boards (SBs) and firm value could be due to SBs leading to lower value or a reflection of low-value firms' greater propensity to maintain SBs. We analyze the causal question using a natural experiment...
View Details
Keywords:
Staggered Board;
Takeover Defense;
Antitakeover Provision;
Proxy Fight;
Tobin's;
Firm Value;
Agency Cost;
Delaware;
Chancery Court;
Airgas;
Governing and Advisory Boards;
Corporate Governance
Cohen, Alma, and Charles C.Y. Wang. "How Do Staggered Boards Affect Shareholder Value? Evidence from a Natural Experiment." Journal of Financial Economics 110, no. 3 (December 2013): 627–641.
- November 2020
- Case
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...
View Details
Keywords:
Mergers and Acquisitions;
Value;
Valuation;
Judgments;
Decision Making;
Cash Flow;
Financial Instruments;
Cognition and Thinking;
Pharmaceutical Industry;
Biotechnology Industry;
United States
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.
- 2015
- Working Paper
Staggered Boards and Shareholder Value: A Reply to Amihud and Stoyanov
By: Alma Cohen and Charles C.Y. Wang
In a paper published in the Journal of Financial Economics in 2013, we provided evidence that market participants perceive staggered boards to be on average value-reducing. In a recent response paper, Amihud and Stoyanov (2015) “contest” our results. They...
View Details
Keywords:
Staggered Boards;
Takeover Defense;
Antitakeover Provision;
Firm Value;
Agency Costs;
Delaware;
Chancery Court;
Airgas;
Governing and Advisory Boards;
Acquisition;
Corporate Governance;
Business and Shareholder Relations;
Delaware
Cohen, Alma, and Charles C.Y. Wang. "Staggered Boards and Shareholder Value: A Reply to Amihud and Stoyanov." Harvard Business School Working Paper, No. 16-097, February 2016.
- 2013
- Tool
Harvard Business Review's Go to Market Tools: Customer Lifetime Value
By: Thomas Steenburgh and Jill Avery
How much are your customers worth? Has your marketing budget been slashed? Need to figure out the best place to invest your time and effort to reach your growth target? HBR's Go to Market Tool helps calculate your customer's lifetime value, allowing you to prioritize...
View Details
Keywords:
Quantitative Analysis;
Tools;
Customer Lifetime Value;
Customer Defection;
CRM;
Customer Relationship Management;
Marketing;
Marketing Strategy;
Customer Focus and Relationships
Steenburgh, Thomas, and Jill Avery. Harvard Business Review's Go to Market Tools: Customer Lifetime Value. Tool. Harvard Business Review Press, 2013. Electronic.
- November 2020
- Supplement
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...
View Details
- February 2013
- Article
Does Shareholder Proxy Access Improve Firm Value? Evidence from the Business Roundtable Challenge
By: Bo Becker, Guhan Subramanian and Daniel B. Bergstresser
We use the Business Roundtable's challenge to the SEC's 2010 proxy access rule as a natural experiment to measure the value of shareholder proxy access. We find that firms that would have been most vulnerable to proxy access, as measured by institutional ownership and...
View Details
Becker, Bo, Guhan Subramanian, and Daniel B. Bergstresser. "Does Shareholder Proxy Access Improve Firm Value? Evidence from the Business Roundtable Challenge." Journal of Law & Economics 56, no. 1 (February 2013): 127–160.
- November 2020
- Teaching Note
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 221-031. When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA)...
View Details
- September 2010 (Revised August 2011)
- Background Note
Pricing, Profits, and Customer Value
By: Frank V. Cespedes, Benson P. Shapiro and Elliot B. Ross
This note discusses how some firms (start-ups and established companies) maximize customer value and profits via their pricing processes. It is aimed at companies that compete on the basis of performance initiatives rather than absolute cost advantages and low price....
View Details
Keywords:
Customer Focus and Relationships;
Customer Value and Value Chain;
Cost;
Price;
Profit;
Performance Effectiveness;
Sales;
Competitive Strategy
Cespedes, Frank V., Benson P. Shapiro, and Elliot B. Ross. "Pricing, Profits, and Customer Value." Harvard Business School Background Note 811-016, September 2010. (Revised August 2011.)
- 2022
- Working Paper
How Do Investors Value ESG?
By: Malcolm Baker, Mark Egan and Suproteem K. Sarkar
Environmental, social, and governance (ESG) objectives have risen to near the top of the agenda for corporate executives and boards, driven in large part by their perceptions of shareholder interest. We quantify the value that shareholders place on ESG using a revealed...
View Details
Keywords:
Investment;
Investment Portfolio;
Corporate Social Responsibility and Impact;
Business and Shareholder Relations;
Environmental Sustainability;
Governance;
Financial Services Industry;
United States
Baker, Malcolm, Mark Egan, and Suproteem K. Sarkar. "How Do Investors Value ESG?" NBER Working Paper Series, No. 30708, December 2022. (Harvard Business School Working Paper, No. 23-028, November 2022.)
- 04 Aug 2022
- News
Restoring Shareholder Confidence When Your Stock Is Down
- Article
Creating Value Together
By: Maxim Sytch and Ranjay Gulati
Conventional wisdom suggests that companies should avoid growing dependent on their business partners. If one company, the thinking goes, grows too dependent on a counterpart by getting the entire input for a particular activity from it and is not able to switch...
View Details
Keywords:
Supply Chain Management;
Performance Improvement;
Partners and Partnerships;
Power and Influence;
Value Creation
Sytch, Maxim, and Ranjay Gulati. "Creating Value Together." Business Intelligence. MIT Sloan Management Review 50, no. 1 (Fall 2008): 12–13.
- 11 Jan 2011
- Working Paper Summaries
Does Shareholder Proxy Access Improve Firm Value? Evidence from the Business Roundtable Challenge
- Program
Creating Brand Value
nurture relationships and create value for both consumers and your business. Key Benefits Through real-life examples of how B2C companies and their marketers are creating brand value, you will expand your understanding of today's branding...
View Details
- January 2001 (Revised March 2002)
- Case
Ford Motor Company's Value Enhancement Plan
By: Andre F. Perold
In April 2000, Ford Motor Co. announced a shareholder Value Enhancement Plan (VEP) to significantly recapitalize the firm's ownership structure. Ford had accumulated $23 billion in cash reserves and under the VEP would return as much as $10 billion of this cash to...
View Details
Keywords:
Restructuring;
Forecasting and Prediction;
Capital Structure;
Cash;
Financial Liquidity;
Policy;
Business and Shareholder Relations;
Value;
Auto Industry
Perold, Andre F. "Ford Motor Company's Value Enhancement Plan." Harvard Business School Case 201-079, January 2001. (Revised March 2002.)
- 2024
- Working Paper
Do Collusive Norms Maximize Profits? Evidence From a Vegetable Market Experiment in India
By: Abhijit Banerjee, Greg Fischer, Dean Karlan, Matt Lowe and Benjamin N. Roth
Social norms have been shown to facilitate anti-competitive behavior in decentralized markets.
We demonstrate that these norms can also reduce aggregate profits. First, we present
descriptive evidence of competition-suppressing norms in Kolkata vegetable markets....
View Details
Banerjee, Abhijit, Greg Fischer, Dean Karlan, Matt Lowe, and Benjamin N. Roth. "Do Collusive Norms Maximize Profits? Evidence From a Vegetable Market Experiment in India." Harvard Business School Working Paper, No. 23-006, July 2022. (Revised April 2024.)